MannKind(MNKD) - 2024 Q3 - Quarterly Results

EXHIBIT 99.1 mannkind MANNKIND CORPORATION REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Conference Call to Begin Today at 4:30 p.m. (ET) • 3Q 2024 Total revenues of $70M; +37$209M; +49% vs. YTD 2023 • YTD 2024 Net income of $20 million; Non-GAAP net income of$45 million • Orphan lung disease studies proceeding as planned o MNKD-101 Phase 3 clinical trial expands globally o MNKD-201 Phase 1 successfully completed; Plan to meet with FDA ...